We of flesh and blood are slave to annoying little things like bias, emotion, and human error. But luckily, robots aren't—and they're slave to us. What better way to keep these human attributes in check than having an algorithm help make critical decisions to ensure that the "voice" of Big Data is always heard?
Deep Knowledge Ventures, a firm that focuses on age-related disease drugs and regenerative medicine projects, says the program, called VITAL, can make investment recommendations about life sciences firms by poring over large amounts of data.
Just like other members of the board, the algorithm gets to vote on whether the firm makes an investment in a specific company or not. The program will be the sixth member of DKV's board. Read entire article here>